Skip to main content
Caplight Logo









Panacro Pharmaceutical Technology

Panacro Pharmaceutical Technology

Private
BeijingHealthcare & Life Scienceshttps://panacro.com/cn/index.html

Last Round

Series B

Dec 18, 2023

Total Funding Raised

$14M

Company Overview

Panacro Pharmaceutical Technology is a contract research organization that provides clinical research and development services for pharmaceutical and biotechnology companies.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

contract research organizationCROclinical trial servicesdrug developmentregulatory affairsclinical data managementelectronic data captureEDCclinical trial management systemCTMSeClinicalbiostatisticspost-marketing researchclinical trial outsourcingpharma R&D services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Panacro Pharmaceutical Technology Comparables

Compare Panacro Pharmaceutical Technology with similar companies based on industry and business-model similarity.

Panacro Pharmaceutical Technology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bestudy (Shanghai) Medical Technology Co., Ltd.
89%
R&G PharmaStudies Co., Ltd.
85%
Yaoyanshe
81%

Panacro Pharmaceutical Technology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BDec 18, 2023
Series AApr 15, 2022
StrategicApr 6, 2020
AngelOct 27, 2016

Key People

Founding team and executive leadership

Leo Zhan

COO

Executive Team

Panacro Pharmaceutical Technology Investors

Notable investors and investment history

Panacro Pharmaceutical Technology investors
InvestorRounds
Huatai Zijin InvestmentStrategic, Angel
Addor CapitalStrategic, Angel
CoStone CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors grew 220% MoM, reaching 1.4K.

  • Apr 6, 2020

    Huatai Zijin Investment and Addor Capital participated.

Panacro Pharmaceutical Technology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Panacro Pharmaceutical Technology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Panacro Pharmaceutical Technology's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Employee Range35
Year Founded2004
Last FundingDec 18, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?